Tesamorelin
Synthetic GHRH analog studied for growth hormone release and lipodystrophy research. 2mg lyophilized powder.
Specifications
| Size | 5mg, 10mg, 20mg |
Description
Research Overview
Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) with a trans-3-hexenoic acid modification at the N-terminus. Research has investigated its stimulation of pituitary GH secretion and its effects on visceral adipose tissue reduction in metabolic studies. Note: while tesamorelin is an FDA-approved drug (Egrifta), these research-grade vials are not FDA-approved drug products.
Specifications
- Quantity: 2mg per vial
- Form: Lyophilized powder
- Purity: ≥99% (HPLC verified)
- Storage: Store the powder refrigerated (2–8°C) or frozen, protected from light and moisture, until the printed expiry. After reconstitution, keep refrigerated (do not freeze); full potency ~1 month, with a noticeable quality drop after ~6 weeks.
For laboratory and research use only. Not for human consumption. This product is not a drug, food, or cosmetic and should not be used as a substitute for medical advice or treatment.
All products are sold strictly for in-vitro research and laboratory use only. Not for human consumption. By purchasing, you agree to our research policy and confirm you are a qualified researcher.